Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery

Clinical Nuclear Medicine

Volumn 26, Issue 8, 2001, Pages 683-688

  Arslan, Nuri ^a   Ilgan, Seyfettin ^a   Yuksel, Dogangun ^a   Serdengecti, Mustafa ^a   Bulakbasi, Nail ^a   Ugur, Omer ^a   Ozguven, Mehmet Ali ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Computed Tomography; In 111 Octreotide; Magnetic Resonance Imaging; Medullary Cancer of Thyroid; Tc 99m (V) DMSA; Ultrasonography

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; PENTETREOTIDE; PENTETREOTIDE IN 111; SUCCIMER TC 99M; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT CANCER; RETROSPECTIVE STUDY; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OCTREOTIDE; PROBABILITY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034919634     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200108000-00004     Document Type: Article

References (23)

1. Advances in the diagnosis and treatment of medullary thyroid carcinoma
2. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma
3. Medullary thyroid carcinoma of the thyroid gland
4. Immunoscintigraphy in medullary thyroid cancer using I-123 or In-111 labeled monoclonal antibody fragment
5. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma
6. Tc-99m Sestamibi and other agents in the detection of metastatic medullary thyroid carcinoma
7. Comparison of 99mTc(V)-DMSA, 201T1 and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid
8. Localization of endocrine-related tumors with radioiodinated analogue of somatostatin
9. In vivo somatostatin receptor imaging in medullary thyroid carcinoma
10. Combined use of In-111 DTPA-Phe-1-Octreotide and I-123 vasoactive intestinal peptide in the localization diagnosis of medullary thyroid cancer
11. Enhanced bilateral somatostatin receptor expression in mediastinal lymph nodes (chimney sign) in occult metastatic medullary thyroid cancer: A typical site of tumor manifestation?
12. A new imaging agent for medullary carcinoma of the thyroid
13. Pentavalent (99mTc) DMSA, (1311) MIBG, and (99mTc) MDP - An evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid
14. Medullary thyroid cancer
15. Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid
16. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma
17. Role of 131-I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours
18. Proceedings of the international workshop on the role of 131-I metaiodobenzylguanidine in the treatment of neural crest tumours
19. Somatostatin receptors and somatostatin content in medullary thyroid carcinoma
20. Expression of somatostatin receptors in peritumoral veins of human tumors
21. Somatostatin-receptor imaging of medullary thyroid carcinoma
22. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
23. Endocrine manifestations of neoplasia